Related Experiment Video
Updated: Feb 26, 2026

10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
26.1K
Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics
Xian-Wu Hua1, Yan-Wen Bao, Zhan Chen
1State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, P. R. China. wufg@seu.edu.cn.
Nanoscale
|July 25, 2017
Summary
Researchers developed novel fluorescent carbon quantum dots (CDs) for mitochondrial imaging and targeted cancer therapy. These cost-effective CDs offer superior photostability and long-term imaging compared to commercial probes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Commercial mitochondrial probes often lack modifiable groups, exhibit poor photostability, and involve complex staining procedures.
- Mitochondria-targeted cancer therapy is promising due to the organelle's susceptibility to reactive oxygen species.
Purpose of the Study:
- To synthesize novel fluorescent carbon quantum dots (CDs) with intrinsic mitochondrial targeting ability.
- To evaluate the CDs for live-cell mitochondrial imaging and mitochondria-targeted photodynamic cancer therapy.
Main Methods:
- One-step hydrothermal synthesis of carbon quantum dots (CDs) using chitosan, ethylenediamine, and mercaptosuccinic acid.
- Conjugation of CDs with rose bengal (RB) to create CDs-RB nanomissiles for drug delivery.
- Assessment of CDs for mitochondrial imaging, photostability, cytotoxicity, and targeted photodynamic therapy efficacy.
Main Results:
- The synthesized CDs demonstrated intrinsic mitochondrial targeting ability without additional ligands.
- CDs exhibited excellent photostability, wash-free, long-term imaging capabilities, and negligible cytotoxicity compared to commercial probes.
- CDs-RB nanomissiles showed efficient cellular uptake, mitochondrial accumulation, and effective mitochondria-targeted photodynamic therapy.
Conclusions:
- Novel fluorescent carbon quantum dots offer a cost-effective and efficient platform for mitochondrial imaging and targeted cancer therapy.
- The developed CD-based nanotheranostics show significant promise for various biomedical applications.
- These CDs overcome limitations of current mitochondrial probes, enabling advanced live-cell imaging and therapy.

